Protective overweight in cardiovascular disease: moving from 'paradox' to 'paradigm'.
Centre for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Germany Department of Cardiology, Campus Virchow, Charité-Universitätsmedizin Berlin, Germany wolfram.doehner@charite.de s.anker@cachexia.de.
Wolfram
W
Doehner
Innovative Clinical Trials, Department of Cardiology and Pneumology, University of Göttingen Medical Center, Göttingen, Germany.
Stephan
S
von Haehling
Innovative Clinical Trials, Department of Cardiology and Pneumology, University of Göttingen Medical Center, Göttingen, Germany wolfram.doehner@charite.de s.anker@cachexia.de.
Stefan D
SD
Anker
D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male
D002317:Cardiovascular Agents